Bio-Rad Laboratories (FRA:BUWA) Additional Paid-In Capital : €426 Mil(As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Bio-Rad Laboratories Additional Paid-In Capital?

Bio-Rad Laboratories's quarterly additional paid-in capital increased from Sep. 2023 (€412 Mil) to Dec. 2023 (€412 Mil) and increased from Dec. 2023 (€412 Mil) to Mar. 2024 (€426 Mil).

Bio-Rad Laboratories's annual additional paid-in capital increased from Dec. 2021 (€391 Mil) to Dec. 2022 (€422 Mil) but then declined from Dec. 2022 (€422 Mil) to Dec. 2023 (€412 Mil).

Bio-Rad Laboratories Additional Paid-In Capital Historical Data

The historical data trend for Bio-Rad Laboratories's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio-Rad Laboratories Additional Paid-In Capital Chart

Bio-Rad Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

369.02

352.95

390.93

422.40

411.80

Bio-Rad Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															432.82	437.38	411.77	411.80	425.62

Bio-Rad Laboratories Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Bio-Rad Laboratories Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Bio-Rad Laboratories's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio-Rad Laboratories (FRA:BUWA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio-Rad Laboratories Inc (FRA:BUWA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BIO.B:USA BIO:USA

Address

1000 Alfred Nobel Drive, Hercules, CA, USA, 94547

Website

https://www.bio-rad.com

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas, Europe and Africa , and Asia-Pacific. Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.

Bio-Rad Laboratories (FRA:BUWA) Headlines

No Headlines